Steve Mertens's most recent trade in NeuroOne Medical Technologies Corp was a trade of 906 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Sept. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 30 Sep 2025 | 906 | 161,329 | - | 0.9 | 805 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 30 Jun 2025 | 906 | 162,235 | - | 0.7 | 614 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 200,000 | 200,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Mar 2025 | 906 | 163,141 | - | 0.8 | 770 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 18 Feb 2025 | 7,376 | 164,047 | - | 1.2 | 8,556 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 31 Jan 2025 | 252 | 171,423 | - | 1.2 | 290 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Dec 2024 | 1,158 | 171,675 | - | 0.8 | 957 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Nov 2024 | 252 | 172,833 | - | 0.6 | 157 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 31 Oct 2024 | 252 | 173,085 | - | 1.0 | 244 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 30 Sep 2024 | 1,158 | 173,337 | - | 1.0 | 1,146 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 31 Aug 2024 | 252 | 174,495 | - | 0.8 | 201 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 31 Jul 2024 | 252 | 174,747 | - | 0.8 | 189 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 30 Jun 2024 | 1,158 | 174,999 | - | 0.8 | 926 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 31 May 2024 | 252 | 176,157 | - | 0.9 | 234 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 30 Apr 2024 | 252 | 176,409 | - | 1.1 | 285 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 21 Apr 2024 | 7,250 | 176,661 | - | 1.2 | 8,338 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 31 Mar 2024 | 252 | 183,911 | - | 1.2 | 302 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 29 Feb 2024 | 252 | 184,163 | - | 1.2 | 305 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 101,743 | 184,415 | - | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 31 Jan 2024 | 252 | 82,672 | - | 1.3 | 315 | Common Stock |
| NeuroOne Medical Tech Corp | Mertens Steve | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 31 Dec 2023 | 252 | 82,924 | - | 1.6 | 398 | Common Stock |
| NeuroOne Medical Tech Corp | Mertens Steve | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 30 Nov 2023 | 252 | 83,176 | - | 1.4 | 365 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 31 Jul 2023 | 252 | 84,436 | - | 1.0 | 257 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 30 Jun 2023 | 252 | 84,688 | - | 1.2 | 302 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 31 May 2023 | 252 | 84,940 | - | 1.2 | 305 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.54 per share. | 30 Apr 2023 | 252 | 85,192 | - | 1.5 | 388 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 50,000 | 85,444 | - | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2023 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.61 per share. | 31 Mar 2023 | 252 | 35,444 | - | 1.6 | 406 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 03 Feb 2023 | 6,054 | 35,696 | - | 1.5 | 8,899 | Common Stock |
| NeuroOne Medical Tech Corp | Steve Mertens | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 41,750 | 41,750 | - | 0 | Common Stock |